Search Results
Jul 10, 2026, 17:00 ET Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Action
MAUREEN BREAKIRON-EVANS, LEO S. MACKAY, JR., ZEIN ABDALLA, FRANCISCO D'SOUZA, KAREN MCLOUGHLIN, RAJEEV MEHTA, GORDON J. COBURN, STEVEN SCHWARTZ, RAMAKRISHNAN CHANDRASEKARAN, JOHN E. KLEIN, JONATHAN CHADWICK, THOMAS M. WENDEL, LAKSHMI
More news about: Cognizant Technology Solutions Corporation
Jul 10, 2026, 16:30 ET Primis Financial Corp. Announces Date for Second Quarter 2026 Earnings Release and Conference Call
Address:Dennis J. Zember, Jr., President and CEOPrimis Financial
More news about: Primis Financial Corp.
Jul 10, 2026, 10:04 ET John Legend's Musical Journey with Singer: Chinese Netizens Hail a "Masterclass"
long-running cross-cultural music IP, Singer 2026 continues to welcome global artists. Past participants include Jessie J, Michael Bublé, Charlie Puth, and Adam Lambert, each delivering unforgettable moments that embody the harmonious blend of Chinese and international pop
More news about: Hunan TV
Jul 10, 2026, 09:00 ET XREAL Opens U.S. Sales of X By XREAL a01+, Bringing Big-Screen AR Glasses to More People for $299
https://www.dropbox.com/scl/fo/1do852tz2bksc9j4cmu66/AMDVG_KozhpkFMywyyIXk1g?rlkey=rsxqlqfp5awbl2oo2rbcpr4yi&st=y6qcbmki&dl=0Media ContactLightspeed PR
More news about: XREAL
Jul 10, 2026, 07:27 ET Breanne J. Kincaid, Ph.D. Joins Bergeson & Campbell, P.C. and The Acta Group as Assistant Toxicologist and Regulatory Scientist
2026 /PRNewswire/ -- Bergeson & Campbell, P.C. (B&C®) and The Acta Group (Acta®) are pleased to announce that Breanne J. Kincaid, Ph.D. has joined our firms as Assistant Toxicologist and Regulatory Scientist. Dr. Kincaid's combination of toxicological training, computational
More news about: Bergeson & Campbell, P.C.
Jul 10, 2026, 03:00 ET EDCare's Evidence-Based Approach to Comprehensive Eating Disorder Recovery Featured on "All Access Hosted by Andy Garcia"
https://hsph.harvard.edu/wp-content/uploads/2024/10/Social-Economic-Cost-of-Eating-Disorders-in-US.pdfBratland-Sanda, S., & Sundgot-Borgen, J. (2013). Eating disorders in athletes: Overview of prevalence, risk factors and recommendations for prevention and treatment. European Journal of Sport
More news about: All Access
Jul 10, 2026, 02:00 ET Kanadevia Group Accelerating Global Expansion of Green Hydrogen-related Businesses
https://drive.google.com/file/d/14cw_k229zmbbvLFgkW5nED9j-6zj8JxT/view?usp=sharingThis agreement aims to strengthen cooperation between the two companies across all stages of project
More news about: Kanadevia Corporation
Jul 09, 2026, 19:03 ET 12 Hours of Freedom: NorthShore Gives People with Incontinence the Ultimate Day Out in Chicago
say yes to the experiences on their bucket list, without worry and shame, when they have protection built to stay dry no matter what," said Adam J. Greenberg, Founder and CEO of NorthShore. NorthShore's Day Out doubles as a thank-you to the
More news about: NorthShore Adult Diapers
Jul 09, 2026, 16:30 ET Arthur J. Gallagher & Co. Acquires Med James, Inc.
the wholesale space and expands RPS's capabilities in the region," said J. Patrick Gallagher, Jr., Chairman and CEO. "I am very pleased to welcome the Med James team to our growing, global family of professionals."Arthur J. Gallagher & Co. (NYSE:AJG), a global insurance brokerage, risk management
More news about: Arthur J. Gallagher & Co.
Jul 09, 2026, 16:29 ET Ameren Corporation Second Quarter 2026 Earnings Webcast set for July 31, 2026
ST. LOUIS, July 9, 2026 /PRNewswire/ -- Martin J. Lyons Jr., chairman, president and CEO of Ameren Corp. (NYSE: AEE), and Leonard P. Singh, executive vice president and CFO of Ameren Corp., will discuss Second Quarter 2026
More news about: Ameren Corporation
Jul 09, 2026, 16:15 ET Arthur J. Gallagher & Co. Announces Second Quarter 2026 Earnings Release And Conference Call Date
/PRNewswire/ -- Arthur J. Gallagher & Co. (NYSE: AJG) will release its second quarter 2026 earnings after the market closes on Thursday, July 30, 2026. A printer-friendly format will be available on the company's website shortly thereafter. In conjunction with this release, J. Patrick Gallagher,
More news about: Arthur J. Gallagher & Co.
Jul 09, 2026, 14:56 ET Feldman Shepherd Files Wrongful Death Lawsuit Against Target Following Toddler's Death from Swallowing Toy Water Bead
Center have warned of the dangers of water bead toys.The litigation is led by Feldman Shepherd product liability attorneys Alan M. Feldman, Daniel J. Mann, Edward S. Goldis and Samuel Mukiibi.Mr. Mann said, "Target should demonstrate the same zeal for protecting children that it does in sending
More news about: Feldman Shepherd Wohlgelernter Tanner Weinstock Dodig LLP
Jul 09, 2026, 13:16 ET /C O R R E C T I O N -- Eli Lilly and Company/
al. Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies. J Prev Alzheimers Dis. 2024;11(4):802–813. Alzheimer's Association. Stages of Alzheimer's.
More news about: Eli Lilly and Company
Jul 09, 2026, 13:00 ET The Paley Center for Media Announces Beyond the Headlines: Jewish Life in America Today
Media's Role in Combating Antisemitism series with this timely event celebrating the vibrancy of Jewish life in America today," said Maureen J. Reidy, President & CEO of The Paley Center for Media. "By exploring the powerful role media can play in fostering understanding and combating
More news about: The Paley Center for Media
Jul 09, 2026, 11:05 ET GLP-1 Boom Drives Rise in Post-Weight-Loss Body Contouring at Blackhawk Plastic Surgery
most others were considering it."We see patients who've gone from 300 pounds down to 150, and their skin is hanging everywhere," said Stephen J. Ronan, MD, FACS, board-certified plastic surgeon and founder of Blackhawk Plastic Surgery & MedSpa. "But that's actually a good problem to have.
More news about: Premier Plastic Surgery Partners
Jul 09, 2026, 11:00 ET McCune Law Group Announces Representation of Victoria Lee Robinson in Matter Involving Tom Sandoval
July 9, 2026 /PRNewswire/ -- McCune Law Group has been retained to represent Victoria Lee Robinson and her father, J. Will Robinson, in a personal injury and domestic violence matter involving Tom Sandoval, a reality television personality known for his apparences on
More news about: McCune Law Group APC
Jul 09, 2026, 10:30 ET Gnomon Alpha Outpaces Peers by +9.6% in Q2 2026 as the New Stock Short-Selling Model Earns 200+ Basis Points in June
By Samuel J. Henry Jr., Independent Market AnalystCHICAGO, July 9, 2026 /PRNewswire/ -- As traditional market correlations fracture under unprecedented macroeconomic pressures, institutional allocators are facing
More news about: Gnomon Alpha LLC
Jul 09, 2026, 10:00 ET Scott+Scott Attorneys at Law LLP and The Schall Law Firm Announce a Notice of Pendency of Class Action Settlement for the Edgio, Inc. Securities Litigation
Civil Action No. 2:23-cv-00691-PHX-DJH Hon. Diane J. HumetewaSUMMARY NOTICE OF (I) PENDENCY OF CLASS ACTION AND PROPOSED SETTLEMENT; (II) SETTLEMENT
More news about: Scott+Scott Attorneys at Law LLP and The Schall Law Firm
Jul 09, 2026, 08:37 ET Aureum Therapeutics Announces Successful Prevention of Recurrent Miscarriage using NomiCell™ Stem Cells in Preclinical Studies
Journal of Translational Medicine demonstrating therapeutic activity of its NomiCell™ product in preventing recurrent miscarriages in the established CBA/J x DBA/2 animal model. The peer-reviewed publication is available at this link
More news about: Aureum Therapeutics
Jul 09, 2026, 08:13 ET ehamarkets lance ehamarkets AI, offrant aux traders du monde entier une assistance intelligente au trading 24h/24, 7j/7
content:https://www.prnewswire.com/news-releases/ehamarkets-lance-ehamarkets-ai-offrant-aux-traders-du-monde-entier-une-assistance-intelligente-au-trading-24h24-7j7-302821880.html
More news about: ehamarkets
Jul 09, 2026, 08:05 ET FDA Approves ENNUMO™ (pegfilgrastim-pccg), Accord BioPharma's Second Pegfilgrastim Biosimilar to NEULASTA® (pegfilgrastim)
Accord BioPharma.Tai E, Guy GP, Dunbar A, Richardson LC. Cost of cancer-related neutropenia or fever hospitalizations, United States, 2012. J Oncol Pract. 2017;13(6):e552-e561.All trademarks, logos and brand names are the property of their respective owners.
More news about: Accord BioPharma
Jul 09, 2026, 08:00 ET CGI partners with the Commonwealth of Massachusetts to launch new statewide financial management system
ongoing efforts to modernize core government operations and strengthen how we manage public resources," said Administration and Finance Secretary Matthew J. Gorzkowicz. "This achievement reflects years of collaboration across agencies and with our partners to deliver a more secure, efficient, and resilient
More news about: CGI Technologies and Solutions, Inc.
Jul 09, 2026, 08:00 ET Freenome Reports Top-Line Readout of Updated SimpleScreen™ CRC Colorectal Cancer Screening Blood Test Met All Primary and Secondary Endpoints
for Colorectal Cancer. JAMA. Published online June 2, 2025. doi: 10.1001/jama.2025.7515.2. Data on file.3. Meester RGS et al. JNCI J Natl Cancer Inst. 2026;118(1):113-120.4. Data on file.
More news about: Freenome Holdings, Inc.
Jul 09, 2026, 06:01 ET Blue Earth Therapeutics announces first participant dosed in Phase 1 clinical trial investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in metastatic castration-resistant prostate cancer
Injection has not received a marketing authorisation in any country or region.References:Gallichio L et al, JNCI J Natl Cancer Inst (2022) 114(11): djac158SEER 22 database, https://seer.cancer.gov/statfacts/html/prost.html,
More news about: Blue Earth Therapeutics
Jul 09, 2026, 05:30 ET Foresee Pharmaceuticals Appoints Brian J. Groch as Chief Commercial Officer to Spearhead Commercial Launch of FP-001 42 mg for Central Precocious Puberty
July 9, 2026 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced the appointment of Brian J. Groch as Chief Commercial Officer, effective July 1, 2026. In this strategic executive role, Brian will oversee Foresee's global commercial launch strategy
More news about: Foresee Pharmaceuticals Co., Ltd.